Aviso Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-688
Closed -$299K 147
2025
Q1
$299K Sell
688
-32
-4% -$12.8K 0.16% 114
2024
Q4
$266K Buy
720
+258
+56% +$108K 0.14% 121
2024
Q3
$240K Sell
462
-104
-18% -$55.6K 0.13% 131
2024
Q2
$307K Sell
566
-24
-4% -$12.7K 0.18% 110
2024
Q1
$306K Buy
590
+55
+10% +$27.4K 0.19% 110
2023
Q4
$252K Buy
+535
New +$247K 0.18% 122

Other funds holding ELV

Aviso Wealth Management's ELV Position: Q2 2025 in Review

Aviso Wealth Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 688 shares — an estimated $299K sold.

Aviso Wealth Management first reported a position in ELV in Q4 2023 and held it in 6 quarters. The position peaked at $307K in Q2 2024. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Aviso Wealth Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Aviso Wealth Management sold 688 Elevance Health shares in Q2 2025, an estimated $299K.
  • Aviso Wealth Management first reported a position in Elevance Health in Q4 2023 and held it in 6 quarters.
  • Aviso Wealth Management's Elevance Health position peaked at $307K in Q2 2024.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Aviso Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.